IOBT vs RCL · $98.2M cap vs P/E 26, rev $9.28B
IO Biotech Inc (IOBT) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
IO Biotech Inc (IOBT) is a biotechnology company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
IOBT does not have a complete income-statement cache yet.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
IOBT currently screens at market cap $98.2M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the IOBT and RCL stock pages for the full models.
Not investment advice.